These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Elimination of ioversol by hemodialysis.
    Author: Ueda J, Furukawa T, Takahashi S, Sakaguchi K.
    Journal: Acta Radiol; 1996 Sep; 37(5):826-9. PubMed ID: 8915301.
    Abstract:
    PURPOSE: The dialysability of ioversol was investigated in 12 patients with chronic renal failure, on 4-h hemodialysis. MATERIAL AND METHODS: One hundred ml of ioversol (320 mg I/ml) was injected in less than 10 min during CT. Hemodialysis was commenced within 30 min of starting the contrast medium injection and was continued for 4 h. Blood was sampled before and at 15 min, 30 min, 1 h, 2 h, and 4 h after the start of hemodialysis. Mean dialysance of ioversol was 114 to 129 ml/min and the elimination rate was 82.5 +/- 5.1% 4 h after starting hemodialysis. The half-life of ioversol during hemodialysis was 1.80 +/- 0.38 h. The only side effects of the ioversol injection were heat sensations, which were experienced by 3 patients. RESULTS: As ioversol was effectively removed from the body during the 4 h of hemodialysis and no severe adverse reactions were observed, we conclude that ioversol is suitable for use in hemodialyzed patients.
    [Abstract] [Full Text] [Related] [New Search]